Back to Screener

Healthcare

Insight Molecular Diagnostics Inc.(IMDX)

Live Price

Offline

$5.59

+3.90% today

1Y Change

+60.24%

Window

Jun 26, 2025 โ†’ Jun 22, 2026

Market Cap
$110.00M
Revenue Growth
+115.6%
EPS Growth
+64.6%
Dividend Yield
0.0%

Coverage: 247 bars ยท Jun 26, 2025 โ†’ Jun 22, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Insight Molecular Diagnostics Inc. (IMDX) is a Healthcare stock with a market cap of $110.00M and listed on NASDAQ. The stock last traded around $5.59 and up 60.2% across the available one-year price window (Jun 26, 2025 โ†’ Jun 22, 2026). Baseline metrics include revenue growth of +115.6%, EPS growth of +64.6%, a dividend yield of 0.0%. What stands out right now is revenue +115.6%, EPS +64.6%, free cash flow -19.5% with operating margin -754.1% and ROIC -197.4%. Valuation already assumes a fairly strong business story at price/sales 26.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines IMDX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

IMDX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

IMDX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

IMDX Max Drawdown

-69.93%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for IMDX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 11, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 11, 26
โ€”
Est -0.26
โ€”
โ€”
Est 227.5B
โ€”
May 11
โ€”
Mar 26, 26
โœ—
-0.27
Est -0.24
-13.7%
1139.0B
Est 285.0B
+299.6%
Mar 26
โ€”
Nov 10, 25
โœ—
-0.34
Est -0.24
-41.7%
260.0B
Est 285.0B
-8.8%
Nov 10
โ€”
Aug 11, 25
โœ—
-0.30
Est -0.23
-30.4%
518.0B
Est 300.0B
+72.7%
Aug 11
โ€”
May 12, 25
โœ—
-0.26
Est -0.24
-8.3%
2138.0B
Est 126.8B
+1586.4%
May 12
โ€”
Mar 24, 25
โœ“
0.48
Est -0.43
+211.6%
1486.0B
Est 158.6B
+837.2%
Mar 24
โ€”
Nov 12, 24
โœ—
-0.98
Est -0.44
-122.7%
115.0B
Est 101.7B
+13.1%
Nov 12
โ€”
Aug 8, 24
โœ“
-0.36
Est -0.56
+35.7%
104.0B
Est 320.0B
-67.5%
Aug 8
โ€”
May 15, 24
โœ—
-1.13
Est -0.67
-68.7%
176.0B
Est 350.0B
-49.7%
May 15
โ€”
Mar 29, 24
โœ—
-1.94
Est -1.57
-23.3%
314.0B
Est โ€”
โ€”
Mar 29
โ€”
Nov 9, 23
โœ“
-0.57
Est -1.52
+62.5%
429.0B
Est 320.0B
+34.1%
Nov 9
โ€”
Aug 10, 23
โœ“
-1.07
Est -2.60
+58.9%
463.0B
Est 360.0B
+28.6%
Aug 10
โ€”
May 11, 23
โœ“
-0.80
Est -2.40
+66.7%
297.0B
Est 350.0B
-15.1%
May 11
โ€”
Mar 29, 23
โœ—
-7.64
Est -0.09
-8385.5%
-3550.0B
Est 1420.0B
-350.0%
Mar 29
โ€”
Nov 10, 22
โœ“
-1.60
Est -2.60
+38.5%
1017.0B
Est 1484.7B
-31.5%
Nov 10
โ€”
Aug 10, 22
โœ“
-1.40
Est -2.60
+46.1%
2067.0B
Est 2705.4B
-23.6%
Aug 10
โ€”
May 11, 22
โœ“
-2.20
Est -2.60
+15.4%
1424.0B
Est 2241.6B
-36.5%
May 11
โ€”
Mar 10, 22
โ€”
-2.00
Est -2.00
0.0%
3589.0B
Est 3523.9B
+1.9%
Mar 10
โ€”
Nov 9, 21
โœ—
-2.20
Est -1.40
-57.1%
984.0B
Est 1753.3B
-43.9%
Nov 9
โ€”
Aug 10, 21
โ€”
-1.60
Est -1.60
0.0%
2030.0B
Est 1570.0B
+29.3%
Aug 10
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener